Literature DB >> 10867787

Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene.

J R Murrell1, A M Hake, K A Quaid, M R Farlow, B Ghetti.   

Abstract

CONTEXT: Alzheimer disease is the most common form of dementia. Mutations in the genes amyloid precursor protein (APP), presenilin 1(PS1) and presenilin 2(PS2) have been found in early-onset familial forms of Alzheimer disease
OBJECTIVE: To determine the cause of dementia in a family with early-onset illness. DESIGN, SETTING, AND PARTICIPANTS: A family with a history of dementia was referred to the Indiana Alzheimer Disease Center, Indianapolis. All the research in this study was done in a university or university hospital. The proband and her 4 siblings took part in the study. The proband, who is still alive, showed symptoms of Alzheimer disease at 38 years of age. Genomic DNA was obtained from blood samples of 5 family members. The APPandPS1genes of the proband were screened for mutations by amplification followed by direct sequencing.
RESULTS: Sequence of exon 17 of the APPgene revealed a single nucleotide (guanine to cytosine) substitution in 1 allele, resulting in an amino acid change at codon 717 (valine to leucine). Each of the proband's siblings were tested for this mutation by direct sequencing. Two of the 4 were found to have the mutation; one of whom was recently clinically diagnosed at the age of 36 years.
CONCLUSIONS: A novel mutation in the APPgene (V717L) has been found in a family with a history of dementia, beginning in the mid to late 30s. The age of onset in this family is earlier than most of the other families with Alzheimer disease who also have APPmutations. Arch Neurol. 2000.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867787     DOI: 10.1001/archneur.57.6.885

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  28 in total

Review 1.  Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.

Authors:  Masashi Kitazawa; Rodrigo Medeiros; Frank M Laferla
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 2.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

Review 3.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2015-01-07       Impact factor: 5.590

4.  Molecular determinants and thermodynamics of the amyloid precursor protein transmembrane domain implicated in Alzheimer's disease.

Authors:  Hao Wang; Laura Barreyro; Davide Provasi; Imane Djemil; Celia Torres-Arancivia; Marta Filizola; Iban Ubarretxena-Belandia
Journal:  J Mol Biol       Date:  2011-03-31       Impact factor: 5.469

Review 5.  Role of ROS and RNS Sources in Physiological and Pathological Conditions.

Authors:  Sergio Di Meo; Tanea T Reed; Paola Venditti; Victor Manuel Victor
Journal:  Oxid Med Cell Longev       Date:  2016-07-12       Impact factor: 6.543

6.  Novel mutations and repeated findings of mutations in familial Alzheimer disease.

Authors:  Ulrich Finckh; Christian Kuschel; Maria Anagnostouli; Efstratios Patsouris; George V Pantes; Stylianos Gatzonis; Elisabeth Kapaki; Panagiota Davaki; Katrin Lamszus; Dimitrios Stavrou; Andreas Gal
Journal:  Neurogenetics       Date:  2005-03-18       Impact factor: 2.660

7.  Presymptomatic Genetic Testing with an APP Mutation in Early-Onset Alzheimer Disease: A Descriptive Study of Sibship Dynamics.

Authors:  K A Quaid; J R Murrell; A M Hake; M R Farlow; B Ghetti
Journal:  J Genet Couns       Date:  2000-08       Impact factor: 2.537

Review 8.  Probing the biology of Alzheimer's disease in mice.

Authors:  Karen H Ashe; Kathleen R Zahs
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

9.  FAD mutations in amyloid precursor protein do not directly perturb intracellular calcium homeostasis.

Authors:  Emily Stieren; Walter P Werchan; Amina El Ayadi; Fuzhen Li; Darren Boehning
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

10.  Overexpression of Histone Deacetylase and Amyloid Precursor Protein in Hepatocellular Carcinoma.

Authors:  Luguang Zhao; Dan He; Mengmeng Jiao; Lingshuo Kong; Chunkui Shao; Junli Chen; Zhigang Fang; Xiaohui Ma; Huifang Chen; Lin Li; Si Luo; Na Zheng; Yunbo Chen; Qi Wang; Shuhuan Fang
Journal:  Technol Cancer Res Treat       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.